Noura Tbeileh
Papers
1
Total Citations
3
H-Index
1
About
Dr. Noura Tbeileh is a pioneering translational researcher whose work centers on advancing personalized oncology, with a particular focus on intrahepatic cholangiocarcinoma (ICC)—a notoriously aggressive liver cancer with a median survival under one year despite standard chemotherapy. Her major contribution lies in leveraging patient-derived organoids as predictive platforms for drug screening, a breakthrough that addresses the critical need for novel therapeutic strategies in ICC, where targetable mutations are scarce. Her landmark 2020 study, cited 3 times, demonstrated the feasibility of using these organoids to tailor treatments, offering a path toward overcoming the dismal prognosis of unresectable ICC. This work underscores her commitment to bridging the gap between preclinical models and clinical reality, providing a foundation for future precision medicine approaches. Dr. Tbeileh’s research not only highlights the urgent need for innovation in rare cancers but also establishes her as a key voice in the fight to improve outcomes for patients with limited options. Her efforts continue to inspire new avenues in personalized drug development.
Research Focus
Key Achievements
Top Papers
- 1